(18.118.141.27)
Users online: 6562     
Ijournet
Email id
 

Research Journal of Pharmacy and Technology
Year : 2023, Volume : 16, Issue : 2
First page : ( 524) Last page : ( 528)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.52711/0974-360X.2023.00089

Development and validation of a RP-HPLC method for the determination of venlafaxine hydrochloride in bulk and pharmaceutical dosage forms

Bhavya Sri K.*, Begum Maimuna, Narmada, Sumakanth Mogili

Department of Pharmaceutical Analysis, RBVRR Women’s College of Pharmacy, Barkatpura, Hyderabad, India

*Corresponding Author E-mail: bhavya.khagga@gmail.com

Online Published on 11 October, 2023.

Abstract

A simple, accurate, precise and rapid reverse phase high performance liquid chromatography method was developed and validated for the analysis of venlafaxine hydrochloride in bulk and marketed pharmaceutical dosage form. The chromatographic separation was carried out using a Phenomenex C18, (250mm × 4.6mm × 5μ) column. The optimum mobile phase consisted of ammonium acetate buffer, methanol (60:40) with pH adjusted to 5. The mobile phase was delivered isocratically at a flow rate of 1mL/min with UV detection at 227nm. Venlafaxine hydrochloride was eluted at 2 minutes. The method was validated for linearity, precision, accuracy, robustness and recovery. The method was linear in the concentration range of 15-165μg/ml with correlation coefficient 0.9997. limit of detection and limit and quantification were found to be 185ng/ml and 563ng/ml respectively.

Top

Keywords

Antidepressant, RP-HPLC, Venlafaxine hydrochloride, Validation.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
809,220,462 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.